IM
Immunovia AB
IMMVF · OTC
$0.01 +0.00% (+$0.00)
Market Cap 30.0M kr
P/E Ratio -
Div. Yield -
ROE 278.79%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 1.27x
P/S 24.88x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 35.78%
Rev. growth 15.81%
FCF growth N/A
Profitability
0 /100
Weak Net margin 7,287.72%
Op. margin 6,770.77%
FCF margin 6,839.85%
Quality
0 /100
Poor ROE 278.79%
ROA 183.25%
Asset turnover 0.03x
Debt
64 /100
Moderate Current ratio 1.57x
Int. coverage -9.66x
Debt/Equity 0.14x
Stability
11 /100
Unstable Rev. volatility 41.78%
EPS volatility 52.92%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre IMMVF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jeff Borcherding
Employees
13
Headquarters
Lund
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report